The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.
Continuous manufacturing in the pharmaceuticals industry is a result of advancements in technology with respect to the production techniques. In the past years, the traditional method of batch manufacturing was followed in the pharmaceuticals industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed many primary issues such as the recall of drugs. The pharmaceuticals industry has recently begun to acknowledge the continuous manufacturing as an option to improve and sustain manufacturing operations.
Lucrative Regions forPharmaceutical Continuous ManufacturingMarkets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Shortage of Medicines
Shortages of essential medicines and drugs are becoming increasingly frequent worldwide. The rising shortage is resulting in burden on the health systems along with additional costs as well as risk to the patients’ health. The patients in need of medicines are failing to receive appropriate doses due to unavailability of medicines. According to WHO Drug Information 2016, shortages of essential medicines have been reported from low, middle, and high-income countries. Medicines shortages pose risks for patient health as a result of non-treatment, under-treatment and possible medication errors from attempts to substitute missing medicines.
The Food and Drug Administration (FDA) states that the reasons for drug shortages occur for various reasons including quality problems, manufacturing inefficiency, delays, and discontinuations. The drugs that are often short in supply include sterile injectable and oncology/cancer treatments. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through implementation of new and advanced systems such as continuous manufacturing.
In 2018, the US FDA developed a new Drug Shortage Task Force to explore the reasons and causes of drug shortages. The Task Force analyzed 163 drugs that went short in supply from 2013 to 2017. Moreover, a survey from The Institute for Safe Medication Practices (ISMP) in 2017 revealed that the treatment category was most commonly involved in drug shortages.
The scenario of drug shortage is also prevalent in the European countries. For instance, according to a report published by The Economist Intelligence Unit Limited in 2017, the prevalence of medicine shortage was highin Europe. The three major causes determined for the shortage included manufacturing, economic and regulatory causes. Thus, to meet the rising demand for biologics and drugs and to curb the lack of drug availability, pharmaceutical continuous manufacturing market holds a promising growth scenario.
Product-BasedInsights
In 2019, the integrated systems segment accounted for the largest market share ofthe global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems than the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization.
Global Pharmaceutical Continuous Manufacturing Market, by Product– 2019 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-BasedInsights
Based on application, the pharmaceutical continuous manufacturing market is segmented into end product manufacturing and API manufacturing. The end product manufacturing segment held a largershare of the market in 2019. However, the API manufacturing segment is estimated to register a higherCAGR in the market during the forecast period.Rise in the number of pharmaceutical companies, technological advancements in continuous manufacturing systems and rise in the demand for pharmaceutical drugs are key drivers forthe growth of the end product manufacturing market.
End User-BasedInsights
Based on end user, the pharmaceutical continuous manufacturing market is segmented into full-scale manufacturing companies and R&D departments. The full-scale manufacturing companies segment held a largershare of the market in 2019. Also, the same segment is estimated to register a higherCAGR in the market during the forecast period.This is attributed to the increasing adoption of continuous technologies to address the challenges related to product quality, drug supply, and operational costs.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Continuous Manufacturing Market: Strategic Insights
Market Size Value in US$ 1,459.53 Million in 2019 Market Size Value by US$ 3,064.38 Million by 2027 Growth rate CAGR of 9.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Continuous Manufacturing Market: Strategic Insights
| Market Size Value in | US$ 1,459.53 Million in 2019 |
| Market Size Value by | US$ 3,064.38 Million by 2027 |
| Growth rate | CAGR of 9.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Partnerships and acquisitions are the mostcommonly adopted strategiesby companies to expand their footprints worldwide and meet the growing demand. The market players most commonly adopt these strategies in order to expand its product portfolio.
For instance, in May 2019, Thermo Fisher Scientific has acquired a drug substance-manufacturing site in Cork, Ireland, from GlaxoSmithKline to meet customer demand for the development and commercial manufacturing of complex active pharmaceutical ingredients (APIs).
Global Pharmaceutical Continuous Manufacturing Market – ByProduct
- Integrated Systems
- Semi-Continuous Systems
- Continuous Granulators
- Continuous Blenders
- Continuous Compressors
- Continuous Coaters
- Continuous Dryers
- Other Semi-Continuous Systems
- Controls
Global Pharmaceutical Continuous Manufacturing Market – By Application
- End Product Manufacturing
- Solid Dosage Manufacturing
- Liquid Dosage Manufacturing
- API Manufacturing
Global Pharmaceutical Continuous Manufacturing Market – By End User
- Full Scale Manufacturing Companies
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- R&D Departments
- Contract Research Organizations
- Research Institutes
Pharmaceutical Continuous ManufacturingMarket– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- GEA Group
- Thermo Fisher Scientific, Inc.
- Glatt GmbH
- Munson Machinery Co., Inc.
- Hosokawa Micron Group
- Coperion GmbH
- Gericke AG
- Powerex Corp
- Freund-Vector Corporation
- Fette Compacting
- LEISTRITZ AG
- KORSCH AG
- ACG
- Cadmach Machinery Co. Pvt. Ltd.
- ALEXANDERWERK AG
- Hovione
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Application ; End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Continuous Manufacturing technology is a method in which continuous development of products is involved to allow faster manufacturing with more productive and profitable products. The continuous manufacturing method in the pharmaceutical attributes to the production of an active component in a compressed unit with a high degree of automation. The market is driven by less time investment, less production cost, faster availability of reliable products in the market.
The growth of the market is attributed to some key driving factors such as increasing shortage of medicines, and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restraint the growth of the market during the forecast years.
Global pharmaceutical continuous manufacturing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for pharmaceutical continuous manufacturing. The federal government in the US and regulatory authorities are supportive towards transition from batch to continuous manufacturing of drugs and APIs which is leading to increasing number of companies and contract manufacturers adopting the techniques thereby leading to the market growth.The Asia Pacific region is expected to account for the fastest growth in the pharmaceutical continuous manufacturing market. In Japan and South Korea, the market is expected to grow owing to factors such as the large population countries such as China and India, increasing focus of market players towards Asian countries to open new production facilities in these regions, rising number of pharmaceutical companies.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmaceutical Continuous Manufacturing Market – By Product
1.3.2 Global Pharmaceutical Continuous Manufacturing Market – By Application
1.3.3 Global Pharmaceutical Continuous Manufacturing Market – By End User
1.3.4 Global Pharmaceutical Continuous Manufacturing Market – By Geography
2. Pharmaceutical Continuous Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmaceutical Continuous Manufacturing – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Global Pharmaceutical Continuous Manufacturing Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Shortage of Medicines
5.1.2 Advantages Offered by Continuous Manufacturing Process
5.2 Key Market Restraints
5.2.1 High Capital Investments
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis
6. Pharmaceutical Continuous Manufacturing Market – Global Analysis
6.1 Global Pharmaceutical Continuous Manufacturing Market Revenue Forecast And Analysis
6.2 Global Pharmaceutical Continuous Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Pharmaceutical Continuous Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Continuous Manufacturing Market– By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9. Pharmaceutical Continuous Manufacturing Market – By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
10. Pharmaceutical Continuous Manufacturing Market – Geographic Analysis
10.1.1 Overview
10.1.2 North America: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.3.1 North America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.4 North America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.4.1 North America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.5 North America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.5.1 North America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.5.2 North America: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.6 North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.7.2.1 US: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.7.3 US: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.7.3.1 US: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.7.4 US: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.7.4.1 US: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.7.4.2 US: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.8 Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.8.2.1 Canada: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.8.3.1 Canada: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.8.4 Canada: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.8.4.1 Canada: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.8.4.2 Canada: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.9 Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.9.2.1 Mexico: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.9.3 Mexico: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.9.3.1 Mexico: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.9.4 Mexico: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.9.4.1 Mexico: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.9.4.2 Mexico: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2 Europe: Pharmaceutical Continuous Manufacturing Market
10.2.1 Overview
10.2.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.4.1 Europe: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.5.2 Europe: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.2.7 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.7.4.2 Germany: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.8 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.8.3.1 UK: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.8.4.2 UK: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.9 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.9.3.1 France: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.9.4.2 France: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.10 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.10.4.2 Spain: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.11 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.11.4.2 Italy: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market
10.3.1 Overview
10.3.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.4.2 Asia Pacific: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.3.6 China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.6.2.1 China: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.6.3.2 China: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.7 Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.7.3.2 Japan: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.8 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.8.3.1 India: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.8.4.2 India: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.9 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.9.4.2 South Korea: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.10 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.10.4.2 Australia: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.3.1 Middle East & Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.4.1 Middle East & Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.5.1 Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.5.2 Middle East & Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country – 2019 & 2027, (%)
10.4.7 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.7.2.1 Saudi Arabia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.7.3.1 Saudi Arabia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.7.4.1 Saudi Arabia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.7.4.2 Saudi Arabia: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.8 UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.8.2.1 UAE: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.8.3 UAE: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.8.3.1 UAE: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.8.4 UAE: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.8.4.1 UAE: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.8.4.2 UAE: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.9 South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
10.4.9.1 South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.9.2.1 South Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.9.3 South Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.9.3.1 South Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.9.4 South Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.9.4.1 South Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.9.4.2 South Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5 South and Central America: Pharmaceutical Continuous Manufacturing Market
10.5.1 Overview
10.5.2 South and Central America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.3.1 South and Central America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.4 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.4.1 South and Central America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.5 South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.5.1 South and Central America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.5.2 South and Central America: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5.6 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.5.7 Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.7.2.1 Brazil: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.7.3 Brazil: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.7.3.1 Brazil: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.7.4 Brazil: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.7.4.1 Brazil: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.7.4.2 Brazil: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5.8 Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.8.2.1 Argentina: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.8.3 Argentina: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.8.3.1 Argentina: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.8.4 Argentina: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.8.4.1 Argentina: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.8.4.2 Argentina: R&D Departments Market, by Type, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic
12. Pharmaceutical Continuous Manufacturing Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 GEA Group
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Coperion GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Gericke AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Glatt GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hosokawa Micron Group
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Munson Machinery Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Powrex Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 THERMO FISHER SCIENTIFIC INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ACG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cadmach Machinery Co. Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Fette Compacting
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Freund-Vector Corporation
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 KORSCH AG
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 LEISTRITZ AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 ALEXANDERWERK AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hovione
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. North America End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. North America Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. North America R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 9. US Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 10. US Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. US End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. US Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. US Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. US R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Canada: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Canada: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 20. Canada: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Canada: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Mexico: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. Mexico: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Mexico: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Europe Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 30. Europe: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 31. Europe: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. Europe: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Europe: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Europe: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Europe: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Germany: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Germany: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Germany: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Germany: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Germany: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Germany: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Germany: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. UK: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 44. UK: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 45. UK: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 46. UK: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 47. UK: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 48. UK: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 49. UK: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 50. France: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 51. France: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 52. France: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 53. France: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 54. France: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 55. France: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 56. France: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 57. Spain: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 58. Spain: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 59. Spain: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 60. Spain: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 61. Spain: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 62. Spain: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. Spain: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 64. Italy: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 65. Italy: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 66. Italy: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 67. Italy: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 68. Italy: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 69. Italy: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 70. Italy: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 72. Asia Pacific: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 73. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 74. Asia Pacific: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 75. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. Asia Pacific: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 77. Asia Pacific: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 78. China: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 79. China: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 80. China: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 81. China: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 82. China: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 83. China: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 84. China: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 85. Japan: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 86. Japan: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 87. Japan: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 88. Japan: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 89. Japan: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 90. Japan: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 91. Japan: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 92. India: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 93. India: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 94. India: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 95. India: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 96. India: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 97. India: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 98. India: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 99. South Korea: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 100. South Korea: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 101. South Korea: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 102. South Korea: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 103. South Korea: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 104. South Korea: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 105. South Korea: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 106. Australia: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 107. Australia: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 108. Australia: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 109. Australia: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 110. Australia: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 111. Australia: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 112. Australia: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 113. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 114. Middle East & Africa: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 115. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 116. Middle East & Africa: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 117. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 118. Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 119. Middle East & Africa: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 120. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 121. Saudi Arabia Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 122. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 123. Saudi Arabia End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 124. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 125. Saudi Arabia Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 126. Saudi Arabia R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 127. UAE: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 128. UAE: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 129. UAE: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 130. UAE: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 131. UAE: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 132. UAE: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 133. UAE: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 134. South Africa: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 135. South Africa: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 136. South Africa: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 137. South Africa: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 138. South Africa: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 139. South Africa: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 140. South Africa: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 141. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 142. South and Central America: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 143. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 144. South and Central America: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 145. South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 146. South and Central America: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 147. South and Central America: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 148. Brazil: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 149. Brazil: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 150. Brazil: Pharmaceutical Continuous Manufacturing Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 151. Brazil: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 152. Brazil: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 153. Brazil: Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 154. Brazil: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 155. Argentina: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 156. Argentina: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 157. Argentina: Pharmaceutical Continuous Manufacturing Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 158. Argentina: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 159. Argentina: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 160. Argentina: Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 161. Argentina: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 162. Recent Growth Strategies In The Pharmaceutical Continuous Manufacturing Market
Table 163. Glossary of Terms, Pharmaceutical Continuous Manufacturing Market
LIST OF FIGURES
Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 2. Pharmaceutical Continuous Manufacturing Segmentation, By Region
Figure 3. Global Pharmaceutical Continuous Manufacturing Market Overview
Figure 4. The Integrated Systems Segment Held Largest Share Of Product Segment In Pharmaceutical Continuous Manufacturing Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Pharmaceutical Continuous Manufacturing Market, By Geography (US$ Million)
Figure 7. Global Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific PEST Analysis
Figure 11. Middle East & Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Global Pharmaceutical Continuous Manufacturing Market – Revenue Forecast And Analysis – 2019- 2027
Figure 14. Global Pharmaceutical Continuous Manufacturing Market – By Geography Forecast And Analysis – 2019- 2027
Figure 15. Market Positioning Of Key Players In Global Pharmaceutical Continuous Manufacturing Market
Figure 16. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
Figure 17. Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 20. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 ( US$ Million)
Figure 21. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 22. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 23. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 24. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 25. Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 26. Pharmaceutical Continuous Manufacturing Market Share, by application, 2019 and 2027 (%)
Figure 27. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
Figure 32. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 33. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 34. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 35. R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 36. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 37. Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 38. North America: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 39. North America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 40. North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
Figure 41. US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Europe: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 45. Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 46. Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
Figure 47. Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 53. Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 54. China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 60. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 61. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country – 2019 & 2027, (%)
Figure 62. Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 66. South and Central America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 67. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
Figure 68. Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 70. Impact of COVID-19 Pandemic in North American Country Markets
Figure 71. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 72. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 73. Impact of COVID-19 Pandemic in Rest of World Country Markets
The List of Companies - Pharmaceutical Continuous Manufacturing Market
- GEA Group
- Coperion GmbH
- Gericke AG
- Glatt GmbH
- Hosokawa Micron Group
- Munson Machinery Co. Inc.
- Powrex Corp
- Thermo Fisher Scientific Inc.
- Freund-vector Corporation
- Fette Compacting
- Alexanderwerk
- LEISTRITZ AG
- KORSCH AG
- ACG
- Cadmach Machinery Co. Pvt. Ltd.
- Hovioneen Aesica
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pharmaceutical Continuous Manufacturing Market
Apr 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)